BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3385785)

  • 21. Prehospital administration of inhaled metaproterenol.
    Eitel DR; Meador SA; Drawbaugh R; Hess D; Sabulsky NK; Bernini R
    Ann Emerg Med; 1990 Dec; 19(12):1412-7. PubMed ID: 2240754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of patient acceptance and inhalation technique of a pressurized aerosol inhaler and two breath-actuated devices.
    Nimmo CJ; Chen DN; Martinusen SM; Ustad TL; Ostrow DN
    Ann Pharmacother; 1993; 27(7-8):922-7. PubMed ID: 8364279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the bronchodilator effects of salbutamol delivered via a metered-dose inhaler with spacer, a dry-powder inhaler, and a jet nebulizer in patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Hajiro T; Mishima M; Izumi T
    Respiration; 1999; 66(2):119-23. PubMed ID: 10202314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurized metered dose inhaler.
    Ekström T; Andersson AC; Skedinger M; Lindbladh C; Ståhl E
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):328-32. PubMed ID: 7719894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer.
    Balzano G; Battiloro R; Biraghi M; Stefanelli F; Fuschillo S; Gaudiosi C; De Angelis E
    J Aerosol Med; 2000; 13(1):25-33. PubMed ID: 10947321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebulized terbutaline and positive expiratory pressure in chronic obstructive pulmonary disease.
    Christensen EF; Nørregaard O; Dahl R
    Pneumologie; 1991 Mar; 45(3):105-9. PubMed ID: 2031046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy. A multi-centre clinical comparison.
    Pierce RJ; McDonald CF; Landau LI; Le Souef PN; Armstrong JG; Mitchell CA; Francis PW; Martin AJ; Musk AW; Antic R
    Med J Aust; 1992 Jun; 156(11):771-4. PubMed ID: 1630347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domiciliary comparison of terbutaline treatment by metered dose inhaler with and without conical spacer in severe and moderately severe chronic asthma.
    O'Reilly JF; Gould G; Kendrick AH; Laszlo G
    Thorax; 1986 Oct; 41(10):766-70. PubMed ID: 3538478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma.
    Laberge S; Spier S; Drblik SP; Turgeon JP
    J Pediatr; 1994 May; 124(5 Pt 1):815-7. PubMed ID: 8176575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter study of nebulized bronchodilator solutions in chronic obstructive pulmonary disease.
    Friedman M
    Am J Med; 1996 Jan; 100(1A):30S-39S. PubMed ID: 8610715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two chamber devices in patients using a metered-dose inhaler with satisfactory technique.
    Fuller HD
    CMAJ; 1986 Sep; 135(6):625-9. PubMed ID: 3530417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients.
    Jasper AC; Mohsenifar Z; Kahan S; Goldberg HS; Koerner SK
    Chest; 1987 Apr; 91(4):614-8. PubMed ID: 3103989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.
    de Jong JW; Koëter GH; van der Mark TW; Postma DS
    Thorax; 1996 Jul; 51(7):684-8. PubMed ID: 8882073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The significance of incorrect spray technic on the consumption of terbutaline in patients with chronic obstructive lung disease].
    Ibsen TB; Svendsen UG
    Ugeskr Laeger; 1990 May; 152(19):1375-8. PubMed ID: 2188408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy and tolerance of terbutaline and budesonide administered via a pressurized aerosol inhaler or a Turbohaler in asthmatic patients].
    Zellweger JP; Anderhub HP; Langloh P
    Schweiz Rundsch Med Prax; 1993 May; 82(19):561-4. PubMed ID: 8506434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terbutaline via pressurised metered dose inhaled (P-MDI) and Turbuhaler in highly reactive asthmatic patients.
    Jackson L; Ståhl E; Holgate ST
    Eur Respir J; 1994 Sep; 7(9):1598-601. PubMed ID: 7995387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Turbuhaler: a new device for dry powder terbutaline inhalation.
    Johnsen CR; Weeke ER
    Allergy; 1988 Jul; 43(5):392-5. PubMed ID: 3046409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of bronchodilator therapy administered by canister versus jet nebulizer.
    Shim CS; Williams MH
    J Allergy Clin Immunol; 1984 Mar; 73(3):387-90. PubMed ID: 6699319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Objective and subjective tremor responses to oral beta 2 agents on first exposure. A comparison of metaproterenol and terbutaline.
    Jenne JW; Ridley DJ; Marcucci RA; Druz WS; Rook JC
    Am Rev Respir Dis; 1982 Oct; 126(4):607-10. PubMed ID: 6751176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response.
    Duarte AG; Momii K; Bidani A
    Respir Care; 2000 Jul; 45(7):817-23. PubMed ID: 10926377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.